Objective
Malaria as a disease has long-since continued to drain the finances, and resources of European entities, and everyone else involved, when trying to contain its negative effects. Most pressing of all, are the millions of innocents lives lost to the disease, with numbers continuing to climb every minute. The Rapid Assessment Malaria (RAM) serves to be the first malaria screening tool, that is able to quantify even the slightest presence of malaria parasites in an individual's blood cells, regardless of symptoms, all within the space of 60 seconds. The device exceeds all competitor offerings on the 6 key metrics defined by the World Health Organization as being pivotal to being a malaria detecting tool; with the top of the list being sensitivity to density of infection.
The objective is to optimize the beta prototype in its magnetic and lighting technical functionalities, in order to obtain the most accurate number of malaria parasites when assessing blood cells.
This will be achieved through continual engineering of current electronics, in conjunction with third-party optical experts, to fine-tune the current prototype in order to be conclusively showcased in clinical trials. Progress with the WHO and major private entities such as Bosch healthcare have already been established ensuring a ready-made sales channel upon European commercialization. The proposed work in Phase 1 of the SME instrument fits into the overall plan to reach market by contributing the financial resources needed to plan a fast sound wider deployment of the RAM solution and its market uptake, specifically in its current dealings with large healthcare organisations as both distributors and end-users of the product.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
- medical and health sciences health sciences infectious diseases malaria
- social sciences economics and business economics monetary and finances
- social sciences economics and business business and management business models
- natural sciences biological sciences zoology invertebrate zoology
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.3.1.3. - Treating and managing disease
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
SME-1 - SME instrument phase 1
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-SMEInst-2016-2017
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
SE1 0BL LONDON
United Kingdom
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.